Recent Finacing
Recent Raise
PEP-Therapy develops cell-penetrating and interfering peptides (CP&IP) to block intracellular protein–protein interactions for targeted cancer therapies, paired with predictive biomarkers and advancing toward Phase I trials.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
